Scalp Micropigmentation: Cost, Fading, and the Safety Gap Nobody Discloses
Evidence-based guide to scalp micropigmentation (SMP): pricing breakdown, fading timelines, FDA pigment realities, CAERS adverse-event data, and provider vetting.
Finasteride, minoxidil, dutasteride, PRP, exosomes, low-level laser therapy, transplant. Evidence ladders by sex and stage.
Evidence-based guide to scalp micropigmentation (SMP): pricing breakdown, fading timelines, FDA pigment realities, CAERS adverse-event data, and provider vetting.
Evidence guide to frontal fibrosing alopecia: why lost hair does not regrow, finasteride and steroid response rates, sunscreen odds ratios, transplant graft survival,…
Evidence-based guide to telogen effluvium: triggers, recovery timeline, how to tell it from pattern hair loss, blood tests, and minoxidil.
Evidence-based guide to traction alopecia: whether edges grow back, staging, the fringe sign, treatment, and prevention for braids, weaves, and extensions.
An evidence-first review of LLLT caps for pattern hair loss. Compares Capillus, iRestore, HairMax, and Theradome, analyzes RCT efficacy data, and maps LLLT's role in…
An evidence-based decision guide comparing FUE, FUT, and DHI hair transplant techniques, detailing real graft survival rates, ischemia times, contraindications, and…
Alopecia areata is autoimmune hair loss, not pattern baldness. Three FDA-approved JAK inhibitors (Olumiant, Litfulo, Leqselvi) finally treat severe disease — with real…
Only two drugs are FDA-approved for pattern hair loss, and both are decades old. An evidence-first guide to minoxidil, finasteride, dutasteride, and the 2026 pipeline…
Platelet-rich plasma is marketed for everything from wrinkles to hair loss. Here is what clinical studies show, what PRP cannot do, what it costs, and what to ask before…